1 |
Which of the following best describes the concept of "beat perception" as it relates to the auditory capabilities of newborn infants?
|
The extraction of a consistent rhythm from a sequence of sounds. |
|
Beat perception is the brain's ability to detect a regular, periodic pulse, or "beat" from a sequence of sounds, even if not every beat is explicitly emphaszied
|
We found that newborn infants exhibited stronger neural responses to deviations in beat positions within isochronous sound sequences. This suggests that they were not merly tracking statistical probabilities of sound transitions but instead extracting a consistent underlying beat. These findings support the idea that beat perception is a biological predisposition present at birth
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
2 |
According to the research, what experimental method is used to differentiate beat perception from statistical learning in newborns?
|
Monitoring brain activity using EEG during auditory stimulation. |
|
The researchers used a rhythmic oddball paradigm with EGG-based mismatch responses to disentangle beat perception from statistical learning in newborns, they presented two types of sequence. Isochronous sequence and Jittered sequence
|
Here, we manipulated the isochrony of sound sequences in order to disentangle statistical learning from beat perception in sleeping newborn infants in an EGG experiment, as previously done in adults and macaque monkey
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
3 |
What does the mismatch response (MMR) in EEG studies indicate about newborns' auditory processing?
|
Sensitivity to regularity violations in sound sequences. |
|
According to the passage, the reason the mismatch response indicates sensitvity t regularity violations is that newborns shows a stronger neural responses when unexpected sounds occurred off the beat in the isochronous sequences
|
Differences in the MMR responses between beat and offbeat position should result from learing the sequential statistical regularities of the sound sequence
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
4 |
What does the term "statistical learning" refer to in the context of auditory processing in newborns?
|
Extraction of regularities from the order of sounds without explicit feedback. |
|
Statistical learning is the brain's ability to extract regularities and patterns from the order of sounds, even without explicit feedback or instruction
|
In the study, newborn infants were presented with sequences of sounds where certain tones frequently followed others, creating predictable patterns. Even without explicit cues or feedback, infants showed neural responses indicating they had learned these sound order regularities. This demonstrates their ability to implicitly extract statistical patterns from auditory input, separate from their perception of a regular beat
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
5 |
Which condition in the EEG study did NOT result in a differentiation between beat and offbeat responses in newborns?
|
Jittered condition. |
|
According to the passage, the jittered condition did not produce differentiation between beat and offbeat responses because the irregular timing disrupted the newborns’ ability to perceive a regular beat. Without consistent timing cues, infants could not form an internal representation of the beat, so their brains did not respond differently to sounds occurring on or off the beat.
|
When sounds were presented with varied, unpredictable intervals (jittered), the mismatch response (MMR) showed no significant difference between deviations occurring on the expected beat positions versus offbeat positions, indicating the absence of beat perception in this condition
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
6 |
Which neural mechanism is thought to underlie the synchronization of movement to a beat?
|
Neural entrainment. |
|
According to the passage, neural entrainment supports beat synchronization because it allows the brain to predict the timing of upcoming beats by aligning its internal rhythms with external sounds. This predictive timing helps coordinate movements precisely with the beat, even when some beats are not explicitly marked by strong sounds.
|
The researchers observed that newborns’ brains showed stronger neural responses to expected beat positions in regularly timed (isochronous) sequences, indicating that their neural activity was entrained to the rhythm. This entrainment likely enables them to anticipate beats and later synchronize movements accordingly
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
7 |
How does beat perception in newborns relate to their later musical abilities?
|
It is fundamental for developing rhythmic coordination and timing. |
|
According to the passage, beat perception in newborns is considered a biological predisposition that provides an early framework for processing rhythm, which is fundamental for musical development. By detecting regular beats, infants can better organize auditory information, making it easier
|
Newborns exhibited stronger neural responses to deviations on the beat in isochronous sequences, suggesting they naturally track rhythm regularities, which likely supports their ability to develop rhythmic skills necessary for music and language later in life
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
8 |
What is the primary purpose of using EEG in studies of auditory processing in newborns?
|
To record brain responses to sounds. |
|
According to the passage, EEG is used because it provides a sensitive and direct measure of newborns' brain responses to subtle changes in auditory patterns, like beat versus offbeat sounds, which cannot be observed through behavior alone. This method enables researchers to identify neural markers such as mismatch responses that indicate how infant process and detect sound regularities
|
The researchers recorded EEG while presenting newborns with rhythmic sound sequences and observed stronger mismatch responses to unexpected sounds on the beat in isochronous sequences, demonstrating beat perception at the neural level despite the infants being asleep
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
9 |
What does an isochronous condition in an auditory study typically involve?
|
A consistent temporal interval between sounds. |
|
According to the passage, the isochronous condition provides a stable temporal framework that enables newborns to extract and anticipate a regular beat from the sound sequence. This regularity is crucial for eliciting neural responses that reflect beat perception rather than just statistical learning
|
In the isochronous condition, sounds were played at perfectly even intervals, and newborns showed stronger mismatch responses to deviations occurring off the expected beat positions, indicating their brains had internally represented the steady rhythm
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
10 |
Which auditory feature is NOT directly studied in the newborn auditory processing research?
|
Language comprehension. |
|
According to the passage, the study focused on how newborns process rhythmic patterns and detect beats as well as how they learn regularities in sound sequences, which relates to the melody recognition. However, it did not address language comprehension
|
The researchers presented newborns with rhythmic sound sequences and measured neural responses to timing deviations, demonstrating sensitivity to beat structure and statistical patterns, but the stimuli did not include speech or language content to assess comprehension.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
11 |
What term is used to describe the appearance of scientific credibility used in the marketing of unproven cell-based therapies?
|
Tokens of scientific legitimacy |
|
According to the passage, unproven cell-based therapies are often marketed using tokens of scientific legitimacy to create an illusion of credibility and trustworthiness. These tokens include the use of scientific jargon, references to preliminary studies, or complex imagery that suggest rigorous research backing, even when strong evidence is lacking.
|
The article describes clinics promoting therapies with technical language and selective presentation of data to persuade patients, despite the absence of regulatory approval or conclusive clinical trials, thereby exploiting the appearance of science to attract customers.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
12 |
According to the article, which of the following is NOT a recognized reporting mechanism for adverse effects from cell and gene therapies?
|
Consumer Protection Agencies |
|
According to the passage, formal adverse event reporting systems like Medwatch, EudraVigilance, TGA, and Clinicaltrials are specifically desgined to collect and monitor safety data from cell and gene therapies, ensuring systematic tracking of potential harms. In contrast, consumer protection agenices do not have specialized frameworks or responsibilites to capture detailed clinical safety information, making them unsuitable as primary reporting mechanisms
|
The article highlights that while regulatory bodies maintain dedicated portals for adverse event reporting to protect patient safety, consumer protection agencies mainly handle issues related to fraud or misleading advertising and do not collect comprehensive clinical safety data
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
13 |
What ethical consideration is primarily challenged by direct-to-consumer marketing of unproven cell and gene therapies?
|
Informed consent processes |
|
According to the passage, direct-to-consumer marketing of unproven cell and gene therapies often involves exaggerated claims and selective presentation of information, which undermines patients’ ability to make truly informed decisions. This misrepresentation challenges the ethical principle of informed consent because patients may agree to treatments without understanding the lack of proven efficacy or the potential risks involved.
|
The article describes clinics advertising these therapies with persuasive but misleading scientific language and testimonials, leading patients to consent based on incomplete or inaccurate information rather than balanced facts.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
14 |
What key feature differentiates proven CGT products from unproven ones according to regulatory standards?
|
Pre-marketing authorization by regulatory bodies |
|
According to the passage, pre-marketing authorization by regulatory bodies is crucial because it confirms that cell and gene therapies have undergone comprehensive clinical testing to demonstrate safety and effectiveness before being made available to patients. This regulatory approval distinguishes proven therapies from unproven ones that may be marketed without adequate scientific evidence or oversight.
|
The articles notes that only therapies which have recieved formal approval, such as, from the FDA, EMA, or TGA, are considered proven, while many clinics offer unapproved treatments that lack this critical validation, increasing risks to patients
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
15 |
Which of the following is a risk associated with unproven CGT products highlighted in the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
16 |
Which of the following is NOT a typical characteristic of unproven CGT products as discussed in the article?
|
Approval by major regulatory agencies |
|
According to the passage, unproven cell and gene therapies often lack approval by major regulatory agencies because they have not undergone the rigorous testing required to establish safety and efficacy. Instead, these products are frequently marketed based on patient testimonials, have unclear scientific rationale, and often lack solid pre-clinical data, which raises concerns about their validity and safety.
|
The articles highlights that many clinics offering unproven therapies do so without regulatory approval, relying instead on anecdotal evidence and charging high prices, which contrasts with approved therapies that have met strict regulatory standards
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
17 |
How do regulatory bodies like the FDA and EMA ensure the safety of CGT products?
|
By requiring rigorous pre-marketing clinical trials |
|
According to the passage, regulatory bodies like the FDA and EMA safeguard patient safety by requiring that cell and gene therapies undergo rigorous clinical trials before market approval. These trials must provide strong evidence of a product’s safety and effectiveness, ensuring only well-tested therapies reach patients
|
The article describes how approved CGT products have passed multiple phases of clinical trials reviewed by regulatory agenices, contrasting with unproven therapies that bypass these steps and pose greater risks to patients
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
18 |
What is the primary goal of the ISCT's position on cell and gene therapies as mentioned in the article?
|
To support evidence-based products and oppose unproven ones |
|
According to the passage, the ISCT’s primary goal is to uphold high scientific and ethical standards by endorsing only cell and gene therapies that have been rigorously tested and proven effective, while opposing those lacking sufficient evidence. This stance aims to protect patients from harm and misinformation caused by unproven treatments.
|
The article highlights that the ISCT issues position statement condemning clinics that market unproven therapies using misleading scientific claims, advocating instead for regulatory oversight and transparent evidence to guide clinical use
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
19 |
What is a potential consequence for patients using unproven CGT products?
|
Risk of serious adverse effects |
|
According to the passage, patients using unproven CGT products face a significant risk of serious adverse effects because these therapies lack rigorous clinical testing and regulatory oversight to ensure safety. Without proper evaluation, harmful side effects may go undetected, putting patients at potential physical harm
|
The article describes cases where patients experienced severe complications, including immune reaction and infections, after receiving unapproved cell-based treatments marketed without sufficient evidence or safety monitoring
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
20 |
What role does the ISCT play in the context of cell and gene therapies?
|
It opposes the premature commercialization of unproven therapies. |
|
The International Society for Cell & Gene Therapy (ISCT) plays a key advocacy and guidance role by promoting ethical standards and supporting evidence-based therapies. It explicitly opposes the early marketing and use of unproven CGT products, which can mislead patients and pose serious health risks
|
The article highlights how the ISCT issues position statement warning against clinics that exploit patients by offering unregulated therapies, and it encourages the responsible developement of CGTs through proper scientific validation and regulatory processes
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|